S-MAC CO., Ltd. completed the acquisition of additional 8.22% stake in Kumho HT, Inc. from Lumimicro Co., Ltd.
June 11, 2020
Share
S-MAC CO., Ltd. (KOSDAQ:A097780) entered into a contract to acquire additional 8.22% stake in Kumho HT, Inc. (KOSE:A214330) from Lumimicro Co., Ltd (KOSDAQ:A082800) for KRW 9.9 billion on January 13, 2020. As part of this transaction, Lumimicro Co., Ltd will sell 2.1 million shares of Kumho for the unit price of KRW 4,700. As part of consideration, down payment of KRW 987 million was paid on January 13, 2020 and the balance of KRW 8.9 billion will be paid on closing on April 30, 2020. As of April 29, 2020, the balance payment of KRW 8.9 billion will be paid on June 30, 2020. This transaction is expected to close on April 30, 2020. As of April 29, 2020, the stock transfer date is June 30, 2020.
S-MAC CO., Ltd. (KOSDAQ:A097780) completed the acquisition of additional 8.22% stake in Kumho HT, Inc. (KOSE:A214330) from Lumimicro Co., Ltd (KOSDAQ:A082800) on June 12, 2020. The transaction is funded through reserved funds
Vivozon Pharmaceutical Co Ltd , formerly Vivozon Healthcare Inc, is a Korea-based company mainly engaged in the manufacture and sale of finished pharmaceutical products. The Company operates its business through three segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of finished medicines such as external skin preparations, antipyretic analgesic, anti-inflammatory drugs and antidiabetic drugs. The Optical Business segment is engaged in the manufacture and sale of finished products and lighting module sets such as general lighting and automotive lighting using light emitting diode (LED) light sources. The Cosmetics Business segment is engaged in the manufacture and sale of cosmetics and cosmetic ingredients.
VIVOZON PHARMACEUTICAL CO., LTD. 
